IP Library › Granted Patent US 8,993,558
Granted Patent B2
US 8,993,558 · App. 13/127,147 · Granted Mar 31, 2015

Compositions comprising a calcium channel blocker or a calmodulin blocker for use in the removal of hyperplastic skin lesions

Inventor: Kenneth W. Adams (North York, CA)
A61K31/549A61K9/0014A61K9/0019A61K9/0034A61K31/277A61K31/4422A61K31/554A61K45/06A61K47/10A61K47/24
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,993,558
App. No.
13/127,147
Granted
Mar 31, 2015
Kind
B2
Abstract

A composition, use of and a method of removing a hyperplastic skin lesion on a mammal comprising administering to the lesion or locus thereof a therapeutically effective amount of a composition comprising a blocker selected from the group consisting of a calcium channel blocker, a metabolite thereof, a calmodulin blocker and a metabolite thereof and a pharmaceutically acceptable diluent or carrier.

Claims (8)

1. A method of removing an hyperplastic skin lesion

of the dermis and epidermis of a mammal, wherein said hyperplastic skin lesion is selected from the group consisting of calluses, corns, plantar warts, genital warts, cutaneous warts, and skin tags, comprising:

administering to said lesion or locus thereof a therapeutically effective amount of a composition comprising a blocker selected from the group consisting of a calcium channel blocker, a calmodulin blocker and a pharmaceutically acceptable diluent or carrier.

2. A method according to claim 1 , wherein said calcium channel blocker is verapamil.

3. A method according to claim 1 , wherein said calcium channel blocker is diltiazem.

4. A method according to claim 1 , wherein said calcium channel blocker is felodipine.

5. A method according to claim 1 , wherein said calmodulin blocker is trifluoperazine.

6. A method according to claim 1 , wherein said composition is in the form of a cream, spray, gel, ointment or patch.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 18, 2017
From: ADAMS, KENNETH W, DR.
To: DR. KENNETH ADAMS MEDICINE PROFESSIONAL CORPORATION
Reel/Frame 042492/0133 →
Priority Claims (1)
CA 2642508 · Oct 31, 2008 · national
Continuity (1)
Related Publication 20110319382A1 · Dec 29, 2011